Aktie 300832 SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Shenzhen New Industries Biomedical Engineering Co., Ltd.

Aktien

300832

CNE100003T39

300832

Schlusskurs Shenzhen S.E.
Andere Börsenplätze
 00:00:00 25.04.2024 		% 5 Tage % 1. Jan.
68.4 CNY -1.08% Intraday Chart für Shenzhen New Industries Biomedical Engineering Co., Ltd. +6.18% -12.53%
25.04. Shenzhen New Industries Biomedical Engineering Co., Ltd. meldet Ergebnis für das erste Quartal bis zum 31. März 2024 CI
12.04. Gewinn von Shenzhen New Industries Biomedical Engineering steigt 2023 um 25% MT

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Shenzhen New Industries Biomedical Engineering Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Shenzhen New Industries Biomedical Engineering Gets Nod to Register Five Devices
Shenzhen New Industries Biomedical Engineering's 2023 Profit Jumps 25%
Shenzhen New Industries Biomedical Engineering Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Shenzhen New Industries Biomedical Engineering Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Shenzhen New Industries' Profit Jumps 32% in H1
Shenzhen New Industries Biomedical Engineering Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Shenzhen New Industries Biomedical Engineering Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 08 June 2023
Shenzhen New Industries Biomedical Engineering's Shareholders Plan To Unload Company Stakes
Certain A Shares of Shenzhen New Industries Biomedical Engineering Co., Ltd. are subject to a Lock-Up Agreement Ending on 12-MAY-2023.
Shenzhen New Industries Biomedical Engineering Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Shenzhen New Industries Biomedical Engineering Co., Ltd. Announces Profit Distribution Proposal for 2022
Shenzhen New Industries Biomedical Engineering Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Shenzhen Yinghe Brain Science Co., Ltd announced that it has received $14.800000 million in funding from Eli Lilly Investment Consulting Shanghai Co., Ltd., Shenzhen New Industries Biomedical Engineering Co., Ltd., Beijing Enlight Media Co., Ltd., Xi'an Xijiao 1896 Capital Management Co., Ltd., Shenzhen Qianhai BangQin Investment Co., Ltd. and other investors.
Shenzhen New Industries Receives Provincial Registration Certificate for Parathyroid Hormone Kit
Shenzhen New Industries Biomedical Engineering Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Shenzhen New Industries Biomedical Engineering Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
Shenzhen New Industries Biomedical Engineering Co., Ltd. Implements Final Cash Dividend for 2021, Payable on 23 June 2022
Shenzhen New Industries Biomedical Engineering Co., Ltd. Approves Cash Dividend for 2021
Shenzhen New Industries Biomedical Engineering Co., Ltd. Announces Profit Distribution Plan for 2021
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 300832 Aktie
  4. Nachrichten Shenzhen New Industries Biomedical Engineering Co., Ltd.
  5. Andere Sprachen